Pancreatic Cancer Research

ResearcherThe University of Texas at San Antonio Health Science CenterActive in the last 2 years

Shamsher Ali Pasha

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5070967545, A5080138924. Sources: OpenAlex.

Their work

Papers
10 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
28
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 5 papers · 2025: 2 papers

Papers 10

  1. Evaluating the Association of Area Deprivation Index (ADI) on Postoperative Outcomes in Pancreatic Adenocarcinoma. First author DOI 10.1002/jso.27996↗
  2. Impact of Environmental Quality on Pancreatic Cancer Outcomes Post Pancreatoduodenectomy: A Retrospective Cohort Study. Co-author DOI 10.1007/s12029-025-01254-4↗
  3. Machine learning to predict completion of treatment for pancreatic cancer. Co-author DOI 10.1002/jso.27812↗
  4. Outcomes of minimally invasive vs. open pancreatoduodenectomies in pancreatic adenocarcinoma: analysis of ACS-NSQIP data. Co-author DOI 10.1007/s00423-024-03454-1↗
  5. Modified 5-Item Frailty Index (mFI-5) may predict postoperative outcomes after pancreatoduodenectomy for pancreatic Cancer. First author DOI 10.1007/s00423-024-03483-w↗
  6. Minorities Face Delays to Pancreatic Cancer Treatment Regardless of Diagnosis Setting. Co-author DOI 10.1245/s10434-024-15352-3↗
  7. ASO Author Reflections: Identifying and Understanding How Vulnerable Populations Are Affected by Delays in Pancreatic Cancer Care. Co-author DOI 10.1245/s10434-024-15476-6↗
  8. Development of a Neoadjuvant Treatment Pathway to Standardize Pancreatic Cancer Care and Improve Outcomes Across a Large Diverse Health System Co-author DOI 10.1101/2023.09.19.23295749↗
  9. Pancreatic Cancer Patient-derived Organoids Can Predict Response to Neoadjuvant Chemotherapy. Co-author DOI 10.1097/sla.0000000000005558↗
  10. Ovarian Metastasis from Pancreatic Ductal Adenocarcinoma. First author DOI 10.1007/s00268-021-06209-x↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daniel A. King · 9 shared papers, 2022–2025 · strength 1.75
  2. Lyudmyla Demyan · 8 shared papers, 2022–2025 · strength 1.54
  3. Danielle K. DePeralta · 7 shared papers, 2022–2025 · strength 1.39
  4. Oliver J. Standring · 7 shared papers, 2022–2025 · strength 1.33
  5. Marcovalerio Melis · 5 shared papers, 2024–2025 · strength 1.11
  6. Matthew John Weiss · 5 shared papers, 2024–2025 · strength 1.11
  7. Elliot Newman · 5 shared papers, 2024–2025 · strength 1.11
  8. Abdullah Khalid · 5 shared papers, 2024–2025 · strength 1.11
  9. Sepideh Gholami · 4 shared papers, 2024–2025 · strength 0.90
  10. Joseph M. Herman · 4 shared papers, 2022–2024 · strength 0.64
  11. Matthew John Weiss · 4 shared papers, 2022–2024 · strength 0.64
  12. Gary Deutsch · 3 shared papers, 2022–2024 · strength 0.49
  13. John Fallon · 2 shared papers, 2024 · strength 0.38
  14. Ruwan Y. Parakrama · 1 shared paper, 2023 · strength 0.15
  15. Leila T. Tchelebi · 1 shared paper, 2023 · strength 0.15
  16. David Arthur Tuveson · 1 shared paper, 2022 · strength 0.11
  17. Jin Peng He · 1 shared paper, 2021 · strength 0.11
  18. William R. Burns · 1 shared paper, 2021 · strength 0.11
  19. Sami Shoucair · 1 shared paper, 2021 · strength 0.11
  20. Kelly J. Lafaro · 1 shared paper, 2021 · strength 0.11
  21. Richard Andrew Burkhart · 1 shared paper, 2021 · strength 0.11
  22. Jun Yu · 1 shared paper, 2021 · strength 0.11
  23. Joseph R. Habib · 1 shared paper, 2021 · strength 0.11
  24. Benedict Kinny‐Köster · 1 shared paper, 2021 · strength 0.11
  25. Christopher Lee Wolfgang · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.